Revisiting the Intractable Barriers Affecting Medication Adherence Among Outpatients with Schizophrenia

• المؤلفون الرئيسيون: Julaeha, -, Umi Athiyah, -, Verra Yuliana, -, J.P Ayuningtyas, -, Andi Hermansyah, -
• التنسيق: مقال PeerReviewed
• اللغة: English; English; English; English
• منشور في: The Association of Biotechnology and Pharmacy (ABAP) 2020
• الموضوعات: R Medicine; RS Pharmacy and materia medica; RS1-441 Pharmacy and materia medica; RS200-201 Pharmaceutical dosage forms
• الوصول للمادة أونلاين: https://repository.unair.ac.id/124438/1/Bukti%20Artikel%20C-19.pdf; https://repository.unair.ac.id/124438/2/Bukti%20Validasi%20dan%20Penilaian%20Karil%20C-19.pdf; https://repository.unair.ac.id/124438/3/Bukti%20Similarity%20C-19.pdf; https://repository.unair.ac.id/124438/4/Bukti%20Korespondensi%20C-19.pdf; https://repository.unair.ac.id/124438/; https://abap.co.in/index.php/home/issue/view/3/1

Medication adherence is one of the foremost problems affecting antipsychotic efficacy in schizophrenia patients. Medication nonadherence among schizophrenia patients has been often estimated > 50%, leading to higher rates of relapse and hospitalization as well as to decreasing cognitive and funct...